Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MESO
MESO logo

MESO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Mesoblast Ltd (MESO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
15.800
1 Day change
2.73%
52 Week Range
21.500
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Mesoblast Ltd (MESO) does not present a strong buy opportunity at this time for a beginner investor with a long-term strategy and $50,000-$100,000 available. The lack of significant positive catalysts, neutral insider and hedge fund activity, and bearish moving averages suggest that the stock is not positioned for immediate growth. While options data indicates a strong bullish sentiment, the absence of recent news, financial data, or analyst ratings makes it difficult to justify a buy recommendation.

Technical Analysis

The technical indicators are mixed. The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is neutral at 50.086, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5), indicating a downward trend. The stock is trading near its pivot level of 14.848, with resistance at 15.562 and support at 14.133.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The options data shows a strong bullish sentiment with a very low put-call ratio for both open interest and volume, indicating that traders are heavily favoring calls over puts.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • Options data indicates strong bullish sentiment. MACD is positive and expanding, suggesting potential upward momentum.

Neutral/Negative Catalysts

  • Bearish moving averages, lack of recent news, no significant insider or hedge fund activity, and no recent congress trading data. Additionally, there is no financial or valuation data available to support a buy decision.

Financial Performance

No financial data available for the latest quarter, making it difficult to assess growth trends or profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for MESO.

Wall Street analysts forecast MESO stock price to rise
1 Analyst Rating
Wall Street analysts forecast MESO stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 15.380
sliders
Low
35
Averages
35
High
35
Current: 15.380
sliders
Low
35
Averages
35
High
35
Jefferies
Hold
to
Buy
upgrade
$3
AI Analysis
2025-11-25
Reason
Jefferies
Price Target
$3
AI Analysis
2025-11-25
upgrade
Hold
to
Buy
Reason
Jefferies upgraded Mesoblast to Buy from Hold with a price target of A$3.30, up from A$3.
Jefferies
David Stanton
Hold
to
Buy
upgrade
$3
2025-11-25
Reason
Jefferies
David Stanton
Price Target
$3
2025-11-25
upgrade
Hold
to
Buy
Reason
As previously reported, Jefferies analyst David Stanton upgraded Mesoblast to Buy from Hold with a price target of A$3.30, up from A$3. Ryoncil continues to be rolled out and the firm forecasts 78 patients will complete therapy in FY26, up from 63, while updating its estimates for fiscal Q2 results and FY26 forecasts.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MESO
Unlock Now

People Also Watch